Lisa L. Cunningham

Last updated

Lisa L. Cunningham
Lisa L. Cunningham.jpg
Born
Lisa Lynn Cunningham
Alma mater University of Tennessee (B.A., M.A.)
University of Virginia (Ph.D.)
Scientific career
Institutions Medical University of South Carolina
National Institute on Deafness and Other Communication Disorders
Theses
Doctoral advisor Federico Gonzalez-Fernandez
Other academic advisors Samuel B. Burchfield
James W. Thelin; Edwin Rubel

Lisa Lynn Cunningham is an American scientist. She is Scientific Director and a senior investigator of sensory cell biology at the National Institute on Deafness and Other Communication Disorders (NIDCD).

Contents

Education

Cunningham received a B.A. and M.A. in Audiology from the University of Tennessee. She was first introduced to the field of audiology by Samuel B. Burchfield. Her 1991 thesis was titled: Effects of click polarity on auditory brainstem responses in man using high-pass noise masking. She completed her thesis under the guidance of her major advisor, James W. Thelin and she credits Ravi Krishnan for his part in its conception. [1] Cunningham completed a Clinical Fellowship in Audiology at Indiana University Health University Hospital. She received a Ph.D. in Neuroscience from the University of Virginia. [2] Her dissertation was titled: Novel roles for the retinal pigment epithelium in expression and turnover of interphotoreceptor retinoid-binding protein. Her doctoral advisor was Federico Gonzalez-Fernandez. [3] Cunningham completed a post-doctoral fellowship in Auditory Neuroscience at the University of Washington with Edwin Rubel. [2]

Career and research

After her post-doc, Cunningham worked as an assistant professor at the Medical University of South Carolina where her lab conducted the initial studies on heat shock protein (HSP)-mediated protection against ototoxic drug-induced hearing loss and hair cell death. This work was funded by a Research Project Grant (R01) from the NIDCD. [2] [4]

In January 2011, Cunningham joined the NIDCD Intramural Division as acting chief of the Section on Sensory Cell Biology. Her research interests build on prior work studying the role of heat shock proteins (HSPs) in protecting hair cells against ototoxic drug–induced hearing loss and hair cell death. As chief, she led a team aimed at understanding the molecular mechanisms underlying the protective effects of HSPs, and translating the findings into clinical therapies to prevent hearing loss caused by exposure to ototoxic drugs. [5]

In November 2014, she became a tenured Senior Investigator. [2] [4]

In April 2021, she became Scientific Director of NIDCD. [6]

Related Research Articles

<span class="mw-page-title-main">Hearing loss</span> Partial or total inability to hear

Hearing loss is a partial or total inability to hear. Hearing loss may be present at birth or acquired at any time afterwards. Hearing loss may occur in one or both ears. In children, hearing problems can affect the ability to acquire spoken language, and in adults it can create difficulties with social interaction and at work. Hearing loss can be temporary or permanent. Hearing loss related to age usually affects both ears and is due to cochlear hair cell loss. In some people, particularly older people, hearing loss can result in loneliness. Deaf people usually have little to no hearing.

<span class="mw-page-title-main">Retinol</span> Chemical compound

Retinol, also called vitamin A1, is a fat-soluble vitamin in the vitamin A family that is found in food and used as a dietary supplement. Retinol or other forms of vitamin A are needed for vision, cellular development, maintenance of skin and mucous membranes, immune function and reproductive development. Dietary sources include fish, dairy products, and meat. As a supplement it is used to treat and prevent vitamin A deficiency, especially that which results in xerophthalmia. It is taken by mouth or by injection into a muscle. As an ingredient in skin-care products, it is used to reduce wrinkles and other effects of skin aging.

<span class="mw-page-title-main">Vestibulocochlear nerve</span> Cranial nerve VIII, for hearing and balance

The vestibulocochlear nerve or auditory vestibular nerve, also known as the eighth cranial nerve, cranial nerve VIII, or simply CN VIII, is a cranial nerve that transmits sound and equilibrium (balance) information from the inner ear to the brain. Through olivocochlear fibers, it also transmits motor and modulatory information from the superior olivary complex in the brainstem to the cochlea.

<span class="mw-page-title-main">Saccule</span> Bed of sensory cells in the inner ear

The saccule is a bed of sensory cells in the inner ear. It translates head movements into neural impulses for the brain to interpret. The saccule detects linear accelerations and head tilts in the vertical plane. When the head moves vertically, the sensory cells of the saccule are disturbed and the neurons connected to them begin transmitting impulses to the brain. These impulses travel along the vestibular portion of the eighth cranial nerve to the vestibular nuclei in the brainstem.

<span class="mw-page-title-main">Organ of Corti</span> Receptor organ for hearing

The organ of Corti, or spiral organ, is the receptor organ for hearing and is located in the mammalian cochlea. This highly varied strip of epithelial cells allows for transduction of auditory signals into nerve impulses' action potential. Transduction occurs through vibrations of structures in the inner ear causing displacement of cochlear fluid and movement of hair cells at the organ of Corti to produce electrochemical signals.

Ototoxicity is the property of being toxic to the ear (oto-), specifically the cochlea or auditory nerve and sometimes the vestibular system, for example, as a side effect of a drug. The effects of ototoxicity can be reversible and temporary, or irreversible and permanent. It has been recognized since the 19th century. There are many well-known ototoxic drugs used in clinical situations, and they are prescribed, despite the risk of hearing disorders, for very serious health conditions. Ototoxic drugs include antibiotics, loop diuretics, and platinum-based chemotherapy agents. A number of nonsteroidal anti-inflammatory drugs (NSAIDS) have also been shown to be ototoxic. This can result in sensorineural hearing loss, dysequilibrium, or both. Some environmental and occupational chemicals have also been shown to affect the auditory system and interact with noise.

<span class="mw-page-title-main">Sensory neuron</span> Nerve cell that converts environmental stimuli into corresponding internal stimuli

Sensory neurons, also known as afferent neurons, are neurons in the nervous system, that convert a specific type of stimulus, via their receptors, into action potentials or graded potentials. This process is called sensory transduction. The cell bodies of the sensory neurons are located in the dorsal ganglia of the spinal cord.

<span class="mw-page-title-main">Usher syndrome</span> Recessive genetic disorder causing deafblindness

Usher syndrome, also known as Hallgren syndrome, Usher–Hallgren syndrome, retinitis pigmentosa–dysacusis syndrome or dystrophia retinae dysacusis syndrome, is a rare genetic disorder caused by a mutation in any one of at least 11 genes resulting in a combination of hearing loss and visual impairment. It is a major cause of deafblindness and is at present incurable.

Auditory neuropathy (AN) is a hearing disorder in which the outer hair cells of the cochlea are present and functional, but sound information is not transmitted sufficiently by the auditory nerve to the brain. Hearing loss with AN can range from normal hearing sensitivity to profound hearing loss.

Presbycusis, or age-related hearing loss, is the cumulative effect of aging on hearing. It is a progressive and irreversible bilateral symmetrical age-related sensorineural hearing loss resulting from degeneration of the cochlea or associated structures of the inner ear or auditory nerves. The hearing loss is most marked at higher frequencies. Hearing loss that accumulates with age but is caused by factors other than normal aging is not presbycusis, although differentiating the individual effects of distinct causes of hearing loss can be difficult.

The visual cycle is a process in the retina that replenishes the molecule retinal for its use in vision. Retinal is the chromophore of most visual opsins, meaning it captures the photons to begin the phototransduction cascade. When the photon is absorbed, the 11-cis retinal photoisomerizes into all-trans retinal as it is ejected from the opsin protein. Each molecule of retinal must travel from the photoreceptor cell to the RPE and back in order to be refreshed and combined with another opsin. This closed enzymatic pathway of 11-cis retinal is sometimes called Wald's visual cycle after George Wald (1906–1997), who received the Nobel Prize in 1967 for his work towards its discovery.

<span class="mw-page-title-main">RBP3</span> Protein-coding gene in the species Homo sapiens

Retinol-binding protein 3, interstitial (RBP3), also known as interphotoreceptor retinoid-binding protein (IRBP), is a protein that in humans is encoded by the RBP3 gene. RBP3 orthologs have been identified in most eutherians except tenrecs and armadillos. An horizontal gene transfer from bacteria has been proposed to explain the evolution of the eye in chordates.

<span class="mw-page-title-main">Amelanism</span> Pigmentation abnormality

Amelanism is a pigmentation abnormality characterized by the lack of pigments called melanins, commonly associated with a genetic loss of tyrosinase function. Amelanism can affect fish, amphibians, reptiles, birds, and mammals including humans. The appearance of an amelanistic animal depends on the remaining non-melanin pigments. The opposite of amelanism is melanism, a higher percentage of melanin.

<span class="mw-page-title-main">Hearing</span> Sensory perception of sound by living organisms

Hearing, or auditory perception, is the ability to perceive sounds through an organ, such as an ear, by detecting vibrations as periodic changes in the pressure of a surrounding medium. The academic field concerned with hearing is auditory science.

Auditory fatigue is defined as a temporary loss of hearing after exposure to sound. This results in a temporary shift of the auditory threshold known as a temporary threshold shift (TTS). The damage can become permanent if sufficient recovery time is not allowed before continued sound exposure. When the hearing loss is rooted from a traumatic occurrence, it may be classified as noise-induced hearing loss, or NIHL.

Electrocochleography is a technique of recording electrical potentials generated in the inner ear and auditory nerve in response to sound stimulation, using an electrode placed in the ear canal or tympanic membrane. The test is performed by an otologist or audiologist with specialized training, and is used for detection of elevated inner ear pressure or for the testing and monitoring of inner ear and auditory nerve function during surgery.

The frequency following response (FFR), also referred to as frequency following potential (FFP) or envelope following response (EFR), is an evoked potential generated by periodic or nearly-periodic auditory stimuli. Part of the auditory brainstem response (ABR), the FFR reflects sustained neural activity integrated over a population of neural elements: "the brainstem response...can be divided into transient and sustained portions, namely the onset response and the frequency-following response (FFR)". It is often phase-locked to the individual cycles of the stimulus waveform and/or the envelope of the periodic stimuli. It has not been well studied with respect to its clinical utility, although it can be used as part of a test battery for helping to diagnose auditory neuropathy. This may be in conjunction with, or as a replacement for, otoacoustic emissions.

Hearing Health Foundation (HHF) is a 501(c)(3) nonprofit organization whose mission is to prevent and cure hearing loss and tinnitus through groundbreaking research, and promote hearing health. In 2011, the Deafness Research Foundation changed its name to Hearing Health Foundation.

Edwin Rubel is an American academic and Developmental Neurobiologist holding the position of emeritus professor at the University of Washington. He was the Founding Director and first Virginia Merrill Bloedel Chair in Basic Hearing Research from 1989 to 2017.

<span class="mw-page-title-main">Ototoxic medication</span>

Ototoxicity is defined as the toxic effect on the functioning of the inner ear, which may lead to temporary or permanent hearing loss (cochleotoxic) and balancing problems (vestibulotoxic). Drugs or pharmaceutical agents inducing ototoxicity are regarded as ototoxic medications.

References

  1. Cunningham, Lisa Lynn (1991). Effects of click polarity on auditory brainstem responses in man using high-pass noise masking (Thesis). OCLC   26076263.
  2. 1 2 3 4 "Principal Investigators". NIH Intramural Research Program. Retrieved April 18, 2019.
  3. Cunningham, Lisa Lynn (1999). Novel roles for the retinal pigment epithelium in expression and turnover of interphotoreceptor retinoid-binding protein (Thesis). OCLC   43506065.
  4. 1 2 "NIDCD Congratulates Dr. Lisa L. Cunningham on Receiving Tenure". NIDCD. August 18, 2015. Retrieved April 18, 2019.
  5. "NIDCD Welcomes Dr. Lisa L. Cunningham". NIDCD. August 18, 2015. Retrieved April 18, 2019.
  6. "Lisa L. Cunningham, Ph.D., named NIDCD scientific director | NIDCD". www.nidcd.nih.gov. April 19, 2021. Retrieved April 27, 2023.
PD-icon.svg This article incorporates public domain material from websites or documents of the National Institutes of Health.